| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |